Found 4 hits for monomerid = 50469369 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Tyrosine-protein kinase receptor TYRO3
(Homo sapiens (Human)) | BDBM50469369
(CHEMBL4295042)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(NC2CCNCC2)cc1 |r,wU:13.12,wD:16.16,3.3,(18.56,-12.04,;19.89,-11.27,;21.22,-12.04,;22.56,-11.27,;22.56,-9.73,;23.89,-12.04,;25.22,-11.27,;25.23,-9.73,;26.55,-8.96,;27.89,-9.72,;29.36,-9.24,;30.28,-10.5,;29.37,-11.75,;30.11,-13.09,;31.65,-13.12,;32.39,-14.47,;31.59,-15.79,;32.33,-17.14,;30.05,-15.76,;29.31,-14.41,;27.89,-11.27,;26.56,-12.04,;30.08,-7.88,;31.62,-7.82,;32.33,-6.46,;31.5,-5.15,;32.21,-3.79,;33.75,-3.72,;34.58,-5.03,;36.12,-4.97,;36.84,-3.61,;36.01,-2.3,;34.46,-2.36,;29.96,-5.22,;29.25,-6.59,)| Show InChI InChI=1S/C28H40N6O/c1-3-4-19(2)31-28-30-17-25-26(18-34(27(25)33-28)23-9-11-24(35)12-10-23)20-5-7-21(8-6-20)32-22-13-15-29-16-14-22/h5-8,17-19,22-24,29,32,35H,3-4,9-16H2,1-2H3,(H,30,31,33)/t19-,23-,24-/m0/s1 | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description
Inhibition of TYRO3 (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229
BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase receptor UFO
(Homo sapiens (Human)) | BDBM50469369
(CHEMBL4295042)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(NC2CCNCC2)cc1 |r,wU:13.12,wD:16.16,3.3,(18.56,-12.04,;19.89,-11.27,;21.22,-12.04,;22.56,-11.27,;22.56,-9.73,;23.89,-12.04,;25.22,-11.27,;25.23,-9.73,;26.55,-8.96,;27.89,-9.72,;29.36,-9.24,;30.28,-10.5,;29.37,-11.75,;30.11,-13.09,;31.65,-13.12,;32.39,-14.47,;31.59,-15.79,;32.33,-17.14,;30.05,-15.76,;29.31,-14.41,;27.89,-11.27,;26.56,-12.04,;30.08,-7.88,;31.62,-7.82,;32.33,-6.46,;31.5,-5.15,;32.21,-3.79,;33.75,-3.72,;34.58,-5.03,;36.12,-4.97,;36.84,-3.61,;36.01,-2.3,;34.46,-2.36,;29.96,-5.22,;29.25,-6.59,)| Show InChI InChI=1S/C28H40N6O/c1-3-4-19(2)31-28-30-17-25-26(18-34(27(25)33-28)23-9-11-24(35)12-10-23)20-5-7-21(8-6-20)32-22-13-15-29-16-14-22/h5-8,17-19,22-24,29,32,35H,3-4,9-16H2,1-2H3,(H,30,31,33)/t19-,23-,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description
Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229
BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase Mer
(Homo sapiens (Human)) | BDBM50469369
(CHEMBL4295042)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(NC2CCNCC2)cc1 |r,wU:13.12,wD:16.16,3.3,(18.56,-12.04,;19.89,-11.27,;21.22,-12.04,;22.56,-11.27,;22.56,-9.73,;23.89,-12.04,;25.22,-11.27,;25.23,-9.73,;26.55,-8.96,;27.89,-9.72,;29.36,-9.24,;30.28,-10.5,;29.37,-11.75,;30.11,-13.09,;31.65,-13.12,;32.39,-14.47,;31.59,-15.79,;32.33,-17.14,;30.05,-15.76,;29.31,-14.41,;27.89,-11.27,;26.56,-12.04,;30.08,-7.88,;31.62,-7.82,;32.33,-6.46,;31.5,-5.15,;32.21,-3.79,;33.75,-3.72,;34.58,-5.03,;36.12,-4.97,;36.84,-3.61,;36.01,-2.3,;34.46,-2.36,;29.96,-5.22,;29.25,-6.59,)| Show InChI InChI=1S/C28H40N6O/c1-3-4-19(2)31-28-30-17-25-26(18-34(27(25)33-28)23-9-11-24(35)12-10-23)20-5-7-21(8-6-20)32-22-13-15-29-16-14-22/h5-8,17-19,22-24,29,32,35H,3-4,9-16H2,1-2H3,(H,30,31,33)/t19-,23-,24-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229
BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50469369
(CHEMBL4295042)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(NC2CCNCC2)cc1 |r,wU:13.12,wD:16.16,3.3,(18.56,-12.04,;19.89,-11.27,;21.22,-12.04,;22.56,-11.27,;22.56,-9.73,;23.89,-12.04,;25.22,-11.27,;25.23,-9.73,;26.55,-8.96,;27.89,-9.72,;29.36,-9.24,;30.28,-10.5,;29.37,-11.75,;30.11,-13.09,;31.65,-13.12,;32.39,-14.47,;31.59,-15.79,;32.33,-17.14,;30.05,-15.76,;29.31,-14.41,;27.89,-11.27,;26.56,-12.04,;30.08,-7.88,;31.62,-7.82,;32.33,-6.46,;31.5,-5.15,;32.21,-3.79,;33.75,-3.72,;34.58,-5.03,;36.12,-4.97,;36.84,-3.61,;36.01,-2.3,;34.46,-2.36,;29.96,-5.22,;29.25,-6.59,)| Show InChI InChI=1S/C28H40N6O/c1-3-4-19(2)31-28-30-17-25-26(18-34(27(25)33-28)23-9-11-24(35)12-10-23)20-5-7-21(8-6-20)32-22-13-15-29-16-14-22/h5-8,17-19,22-24,29,32,35H,3-4,9-16H2,1-2H3,(H,30,31,33)/t19-,23-,24-/m0/s1 | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 107 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description
Inhibition of FLT3 (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229
BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this
Ligand-Target Pair | |
Search and Browse
